BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025
BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, will release its second quarter 2025 financial results after market close on Thursday, August 7, 2025.
The company will host a conference call and webcast at 4:30 PM ET where management will discuss financial results and provide a business update. Investors can access the webcast through BioLife's website or join via phone using the provided toll-free numbers.
BioLife Solutions (NASDAQ: BLFS), uno dei principali sviluppatori e fornitori di prodotti e servizi per la bioproduzione nel mercato della terapia cellulare e genica, pubblicher脿 i suoi risultati finanziari del secondo trimestre 2025 dopo la chiusura del mercato di gioved矛 7 agosto 2025.
L'azienda terr脿 una conference call e una webcast alle 16:30 ET durante le quali il management discuter脿 i risultati finanziari e fornir脿 un aggiornamento sul business. Gli investitori potranno accedere alla webcast tramite il sito web di BioLife o partecipare telefonicamente utilizzando i numeri verdi forniti.
BioLife Solutions (NASDAQ: BLFS), un destacado desarrollador y proveedor de productos y servicios de bioproducci贸n para el mercado de terapia celular y g茅nica, publicar谩 sus resultados financieros del segundo trimestre de 2025 despu茅s del cierre del mercado el jueves 7 de agosto de 2025.
La compa帽铆a realizar谩 una llamada conferencia y una transmisi贸n en vivo a las 4:30 PM ET donde la direcci贸n discutir谩 los resultados financieros y ofrecer谩 una actualizaci贸n del negocio. Los inversores podr谩n acceder a la transmisi贸n a trav茅s del sitio web de BioLife o unirse por tel茅fono utilizando los n煤meros gratuitos proporcionados.
BioLife Solutions (NASDAQ: BLFS)電� 靹疙彫 氚� 鞙犾爠鞛� 旃橂 鞁滌灔鞚� 鞙勴暅 靸濍靸濎偘 鞝滍拡瓿� 靹滊箘鞀るゼ 靹犽弰鞝侅溂搿� 臧滊皽 氚� 瓿店笁頃橂姅 旮办梾鞙茧, 2025雲� 2攵勱赴 鞛 瓴瓣臣毳� 2025雲� 8鞗� 7鞚� 氇╈殧鞚� 鞛� 毵堦皭 頉勳棎 氚滍憸頃� 鞓堨爼鞛呺媹雼�.
须岇偓电� 霃欕秬 鞁滉皠 鞓ろ泟 4鞁� 30攵�鞐� 旎嵓霟办姢 旖滉臣 鞗轨簮鞀ろ姼毳� 歆勴枆頃橂┌, 瓴届榿歆勳澊 鞛 瓴瓣臣毳� 雲检潣頃橁碃 靷梾 順勴櫓鞚� 鞐呺嵃鞚错姼頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� BioLife 鞗轨偓鞚错姼毳� 韱淀暣 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃橁卑雮� 鞝滉车霅� 氍措 鞝勴檾氩堩樃毳� 鞚挫毄頃� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟.
BioLife Solutions (NASDAQ : BLFS), un d茅veloppeur et fournisseur de premier plan de produits et services de bioproduction pour le march茅 des th茅rapies cellulaires et g茅niques, publiera ses r茅sultats financiers du deuxi猫me trimestre 2025 apr猫s la cl么ture du march茅 le jeudi 7 ao没t 2025.
La soci茅t茅 organisera une conf茅rence t茅l茅phonique et une webdiffusion 脿 16h30 ET o霉 la direction discutera des r茅sultats financiers et fournira une mise 脿 jour commerciale. Les investisseurs pourront acc茅der 脿 la webdiffusion via le site web de BioLife ou rejoindre par t茅l茅phone en utilisant les num茅ros gratuits fournis.
BioLife Solutions (NASDAQ: BLFS), ein f眉hrender Entwickler und Anbieter von Bioproduktionsprodukten und -dienstleistungen f眉r den Zell- und Gentherapiemarkt, wird seine Finanzergebnisse f眉r das zweite Quartal 2025 nach B枚rsenschluss am Donnerstag, den 7. August 2025 惫别谤枚蹿蹿别苍迟濒颈肠丑别苍.
Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und Webcast veranstalten, bei der das Management die Finanzergebnisse besprechen und ein Gesch盲ftsupdate geben wird. Investoren k枚nnen den Webcast 眉ber die Website von BioLife verfolgen oder telefonisch 眉ber die bereitgestellten geb眉hrenfreien Nummern teilnehmen.
- None.
- None.
To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers. 聽A webcast replay will be available approximately two hours after the call and will be archived on for 90 days.聽
About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit or follow BioLife on and .
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
[email protected]
Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
[email protected]
View original content to download multimedia:
SOURCE BioLife Solutions, Inc.
FAQ
When will BioLife Solutions (BLFS) report Q2 2025 earnings?
How can I listen to BioLife Solutions' Q2 2025 earnings call?
What time is BioLife Solutions' Q2 2025 earnings call?
How long will BioLife Solutions' Q2 2025 earnings webcast be available?
